Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE

Clinical trial NCT03488420 · COMPLETED

Trial details

NCT number: NCT03488420
Sponsor: Montreal Heart Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation and Flutter Valvular Heart Disease

Start date: 2019-04-30
Primary completion: 2025-03-21
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.